“首乌降脂汤”对大鼠食物性高脂血症的预防作用研究

本试验就“首乌降脂汤”对大鼠食物性高脂血症的预防作用进行了试验研究。结果能呈现剂量依赖性地抑制高血脂模型大鼠血清ＴＣ、ＴＧ、ＬＤＬ－Ｃ的升高及ＨＤＬ－Ｃ的降低并同时降低血清中脂质过氧化物的水平。     

辛伐他丁治疗冠心病高血脂症临床观察

目的观察辛伐他丁对冠心病高血脂症患者血清脂质的影响。方法冠心病高血脂症病人５０例,均有血脂（ＴＣ、ＴＧ、ＨＤＬ－Ｃ、ＬＤＬ－Ｃ或４项中任何一项）异常。服用辛伐他丁,５～２０ｍｇ,每日１次,晚间顿服,疗程８周。服药前后晨起空腹查血脂以作自身对照。结果对高ＴＣ下降有效率达９１．５％,对高ＬＤＬ－Ｃ下降有效率达８２．５％,对高ＴＧ下降有效率达７６．２％,对低ＨＤＬ－Ｃ增高有效率为７２．２％。其中对ＴＣ、ＬＤＬ－Ｃ治疗８周有极显著意义（Ｐ＜０．０１）,,对ＴＧ下降、ＨＤＬ－Ｃ升高８周后有显著意义（Ｐ＜０．０５）。治疗期间不良反应轻微。结论辛伐他丁可作为冠心病患者减少ＣＨＤ事件发病率及住院率的理想药物。     

浒苔多糖的降血脂及其对SOD活力和LPO含量的影响

浒苔多糖剂量１５０ｍｇ／ｋｇ可使高胆固醇血症小鼠血清胆固醇下降２２％,剂量１６８ｍｇ／ｋｇ可使高脂血症大鼠ＴＣＨ和ＴＧ分别降低５８％和６１％,ＨＤＬ升高２７％,剂量２５０ｍｇ／ｋｇ可分别提高血清、脑和肝ＳＯＤ活力３３％、１１８％和２２４％,剂量１６８ｍｇ／ｋｇ对高血脂大鼠血清和心脏ＬＰＯ含量降低３５％和４６％。     

浒苔多糖的降血脂及其对SOD活力和LPO含量的影响

浒苔多糖剂量１５０ｍｇ／ｋｇ可使高胆固醇血症小鼠血清胆固醇下降２２％,剂量１６８ｍｇ／ｋｇ可使高脂血症大鼠ＴＣＨ和ＴＧ分别降低５８％和６１％,ＨＤＬ升高２７％,剂量２５０ｍｇ／ｋｇ可分别提高血清、脑和肝ＳＯＤ活力３３％、１１８％和２２４％,剂量１６８ｍｇ／ｋｇ对高血脂大鼠血清和心脏ＬＰＯ含量降低３５％和４６％。     

有氧运动对高胆固醇血症大鼠肝脏低密度脂蛋白受体活性调节…

本文研究了实验性在醇血症大鼠肝脏低密度脂蛋白受体（ＬＤＬ－Ｒ）活性变化及有氧运动时ＬＤＬ－Ｒ活性调节的影响,发现,高脂（ＨＣ）组肝组织匀浆ＬＤＬ－ＲＩ自古以来生较正常对照（ＮＣ）组降低３７％（Ｐ〈０．０５）,同时血清大醇（ＴＣ）、低密度脂收白胆固醇（ＬＤＬ－Ｃ）及血清栽脂蛋白Ｂ（ＡｐｏＢ）均显著高于ＮＣ组（Ｐ〈０．０１）;高脂＋运动（ＨＥ）组ＴＣ、ＬＤＬ－Ｃ及ＡｐｏＢ均明显低于ＨＣ组,而ＬＤＬ－Ｒ     

有氧运动对小鼠高脂血症及脂蛋白代谢的影响

本研究以高胆固醇饮食小鼠为实验对象,观察有氧运动对脂质水平异常的动物个体血脂及脂蛋白代谢的影响。结果显示,经１１周有氧耐力训练后,高脂膳食＋运动组小鼠血浆ＴＧ、ＴＣ及ＬＤＬ－Ｃ水平均显著低于高脂膳食组（Ｐ＜０．０５）,而ＨＤＬ－Ｃ／ＴＣ和ＨＤＬ－Ｃ／ＬＤＬ－Ｃ比值均显著高于高脂膳食组（Ｐ＜０．０５）。表明长期有氧耐力训练能显著改善高胆固醇饮食小鼠血脂及脂蛋白代谢状况。     

肠道有益菌群增效剂对高脂血症大鼠模型的影响

实验用血脂检查法,探讨对人工高脂血症大鼠模型灌胃肠道有益菌群增效剂９６０１（ 青春双歧杆菌加低聚木糖） 与９６０２ 青春双歧杆菌加葡萄糖酸钙微生态调节剂,１４ｄ 后检测血清总胆固醇（ＣＨ） 和甘油三酯（ＴＧ） 水平。结果表明：９６０１ 与自然恢复组比有显著差异,Ｐ＜ ０．０１ ,ＣＨ 降低率为３３ ％ ,ＴＧ 降低率为４４ ％ ;９６０２ 与自然恢复组别有显著差异,Ｐ＜ ０．０１ ,ＣＨ 降低率为４１ ％ ,ＴＧ 降低率为４８ ％ ;９６０１ 与三株口服液组比Ｐ＜ ０．０１ ,ＣＨ 降低率为３９ ％ ,ＴＧ降低率为４３ ％ 。１４ｄ 后９６０１ 与９６０２ＣＨ 与ＴＧ 水平均已恢复到正常水平,而自然恢复ＣＨ 仍高２５ ％ ,ＴＧ 仍高１７ ％ ,尚未恢复到正常水平。     

有氧运动对高胆固醇血症大鼠肝脏低密度脂蛋白受体活性调节的影响

本文研究了实验性高胆固醇血症大鼠肝脏低密度脂蛋白受体（ＬＤＬＲ）活性变化及有氧运动时ＬＤＬＲ活性调节的影响。发现,高脂（ＨＣ）组肝组织匀浆ＬＤＬＲ活性较正常对照（ＮＣ）组降低３７％（Ｐ＜０．０５）,同时血清总胆固醇（ＴＣ）、低密度脂蛋白胆固醇（ＬＤＬＣ）及血清载脂蛋白Ｂ（ＡｐｏＢ）均显著高于ＮＣ组（Ｐ＜０．０１）;高脂＋运动（ＨＥ）组ＴＣ、ＬＤＬＣ及ＡｐｏＢ均明显低于ＨＣ组,而ＬＤＬＲ活性则较ＨＣ组增高２６％（Ｐ＜０．０５）。结果提示：（１）高胆固醇负荷时细胞可通过下行调节影响ＬＤＬＲ活性;（２）运动可能通过增加对细胞内胆固醇利用和降解,反馈作用于下行调节过程影响ＬＤＬＲ的合成,增加对ＬＤＬＣ摄取而显著改善血脂水平。     

刺五加在大鼠实验性肝癌诱发过程中作用的探讨

目的探讨大鼠实验性肝癌发病中刺五加对肌体免疫功能和抗氧化酶活性的影响。方法４６只ＳＤ雄性大鼠被随机分成对照组（喂普通饲料）、３－甲基４－双甲氨基偶氮苯（３－Ｍｅ－ＤＡＢ）组（喂含０．０６％３Ｍｅ－ＤＡＢ饲料 １０周）和刺五加组（饲喂同 ３－Ｍｅ－ＤＡＢ外、另加入刺五加 ４．５ｇ／ｋｇ饲料,用常规方法检测全血谷光甘肽过氧化物酶（ＧＳＨ－ＰＸ）、血清超氧化物歧化酶（ＳＯＤ）活性和丙二醛（ＭＤＡ）含量,用微量化学发光造检测吞噬细胞活性（ＰＭＮ－ＣＬ）。结果１．ＰＭＮ－ＣＬ检测峰值、积分值和吞噬细胞指数,３－ＭｅＤＡＢ组较正常组和刺五加组均有显著升高（Ｐ＜０．０５和Ｐ＜０．０１）２．全血ＧＳＨ－ＰＸ活性、ＳＯＤ活性,刺五加组较３－ＭｅＤＡＢ组均有显著升高（Ｐ＜０．０５）。ＭＤＡ含量刺五加组和３－ＭｅＤＡＢ组均较正常组升高（均Ｐ＜０．０５）。结论刺五加在大鼠实验性肝癌诱发过程中有提高抗氧化酶活性和对抗致癌剂引起的机体中性粒细胞吞噬功能代偿性增高的作用。     

交感传出在大鼠糖尿病性痛过敏中的作用

交感传出和前列腺素（ＰＧｓ）在周围神经不全损伤和炎症所引起的痛过敏中起重要作用,它们对糖尿病性痛过敏影响尚不清楚。本工作先给大鼠腹腔注射６－羟多巴胺（６－ＯＨＤＡ）损毁交感节后神经元（ＳＰＧＮｓ）末梢后,再给予链脲佐菌素（ＳＴＺ）以建立６－ＯＨＤＡ糖尿病大鼠模型,在连续４周的观察中这组大鼠伤害性爪回缩阈值（ＮＰＷＴ）和甩尾反向潜伏期（ＴＥＬ）没有明显变化,而糖尿 病组大鼠的痛阈显著降低,并伴有痛过     

进口普罗布考治疗高脂血症的疗效观察

目的:观察进口普罗布考对高脂血症患者的降脂作用,并评价其疗效。方法:纳入符合要求的高脂血症患者264例,应用优效性设计,并随机分为实验组(普罗布考)和对照组(安慰剂),其中实验组127例,对照组137例。检测总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、氧化低密度脂蛋白(oxLDL)等血脂指标;分别于访视0、访视2、访视3时进行测量,共观察8周。结果:实验后4周及8周TC与LDL-C均较实验前降低,且普罗布考对TC和LDL-C的降低作用明显优于安慰剂;实验后4周及8周oxLDL在两组间均无明显降低,且试验后普罗布考与安慰剂组间无差异;实验后4周及8周普罗布考对TG均有降低趋势,但是与安慰剂相比没有统计学意义;而普罗布考降低HDL-C较安慰剂显著。结论:本试验证实进口普罗布考对降低中国高血脂症患者血脂中TC、LDL-C、HDL-C有明显作用,适宜推广。     

聚焦超声辐射高血脂大鼠涌泉穴对血脂水平的影响

目的研究聚焦超声辐射涌泉穴对血脂的影响.方法采用高脂饲料喂养建立高血脂大鼠模型,通过聚焦超声辐射高血脂模型大鼠涌泉穴,测定大鼠血清总胆固醇(tota cholesterol, TC)、甘油三脂 (triacylglycerol, TG)、高密度脂蛋白胆固醇(high density lipoprotein, HDL-c)和低密度脂蛋白胆固醇(low density lipoprotein, LDL-c)等指标.结果检测血清TC、TG、HDL-C、LDL-C水平,聚焦超声辐照涌泉穴可明显降低高血脂模型大鼠血清TC、TG(P＜0.05),而超声治疗组和针刺组无明显差异.结论聚焦超声辐射高血脂大鼠的涌泉穴位,可明显降低TC、TG,有调节血脂的作用.     

高脂血症大鼠血小板活化功能分析

目的分析高脂血症大鼠血小板功能的变化。方法24只Wistar大鼠随机分为正常对照组、高脂血症模型组,4周后检测两组大鼠的血脂：总胆固醇（CHO）、甘油三酯（TG）、低密度脂蛋白胆固醇（LDL-C）、高密度脂蛋白胆固醇（HDL-C）水平。应用流式细胞术检测血小板表面a-颗粒膜糖蛋白（CD62P）的表达、酶联免疫法测定血浆中α颗粒膜蛋白．140（GMP140）浓度。所有数据采用Excel软件建库,SPSS11．5统计软件进行分析。结果正常对照组与高脂血症组CHO、TG、LDL-C、HDL-C,CHO分别是1．846mmol／L VS 13．779mmol／L、0．999mmol／L vs 0．746mmol／L、0．164mmol／L vs 10．680mmol／L、0．583mmol／L vs 0．195mmol／L。CD62P、GMP140水平分别为10．089％ vs 25．169％、10．665ng/mL vs 27．045．g／mL。结论高脂血症能够促使血小板活化。     

翻白草对大鼠和家兔高血脂模型的降血脂作用

目的探讨翻白草对高血脂大鼠和家兔的降血脂作用。方法采用Wistar大鼠60只（其中50只为高脂饲料诱导成高血脂动物模型,10只为空白对照组）,家兔36只（其中30只为高脂饲料诱导成高血脂动物模型,6只为空白对照组）。随机分为6组（翻白草大、中、小3个剂量组,模型组,脂必妥对照组,空白对照组）。连续给药6周,分别于给药后第4周、第6周采血,检测血清中胆固醇（TC）、甘油三脂（TG）及低密度脂蛋白（LDL）浓度。结果翻白草各给药组与模型组比较,给药后第4周,翻白草可降低高血脂大鼠和家兔血清中TC、TG、LDL的含量（P〈0.05）;给药后第6周,可显著降低高血脂大鼠和家兔血清中TC、TG、LDL的含量（P〈0.01）。结论翻白草具有很好的降血脂作用。     

大头金蝇幼虫油脂对小鼠的降血脂作用

用健康昆明种小鼠建立高脂血症模型,同时用不同剂量的大头金蝇Chrysomyia megacepha la (Fabricius)幼虫油脂灌胃5周,摘除眼球取血,用试剂盒检测血脂值,光学显微镜观察小鼠肝脏病理变化。结果表明：大头金蝇幼虫油脂处理组小鼠血清胆固醇(TC)、甘油三酯（TG）、低密度脂蛋白胆固醇(LDL-C)水平显著降低,低剂量、中剂量和高剂量油脂处理组小鼠TG的浓度较高脂模型组小鼠分别下降20.70%、48.98%和56.06%;高脂模型组小鼠血清TC高达4.59 mmol/L,低剂量、中剂量和高剂量油脂处理组小鼠TC浓度较高脂模型组小鼠分别下降16.99%、23.52%和25.49%;高密度脂蛋白胆固醇（HDL-C）升高明显,低剂量、中剂量和高剂量油脂处理组小鼠HDL-C较高脂模型组小鼠升高11.74%、18.04%和18.95%,并呈现一定的剂量-效应关系;连续饲喂大头金蝇幼虫油脂对小鼠肝细胞有一定保护作用。提示大头金蝇幼虫油脂具有治疗小鼠高脂血症的作用。     

Protective effects of thymoquinone on the neuronal injury in frontal cortex after chronic toluene exposure

The aim of this study was designed to evaluate the possible protective effects of thymoquinone (TQ) on the neuronal injury in the frontal cortex after chronic toluene exposure in rats. The rats were randomly allotted into one of three experimental groups: A (control), B (toluene treated) and C (toluene treated with TQ); each group contain 10 animals. Control group received 1ml normal saline solution and toluene treatment was performed by inhalation of 3,000 ppm toluene, in a 8 h/day and 6 day/week order for 12 weeks. The rats in TQ treated group was given TQ (50 mg/kg body weight) once a day orally for 12 weeks starting just after toluene exposure. Tissue samples were obtained for histopathological investigation. To date, no histopathological changes of neurodegeneration in the frontal cortex after chronic toluene exposure in rats by TQ treatment have been reported. In this study, the morphology of neurons in the TQ treatment group was well protected. Chronic toluene exposure caused severe degenerative changes, shrunken cytoplasma, severely dilated cisternae of endoplasmic reticulum, markedly swollen mitochondria with degenerated cristae and nuclear membrane breakdown with chromatin disorganization in neurons of the frontal cortex. We conclude that TQ therapy causes morphologic improvement on neurodegeneration in frontal cortex after chronic toluene exposure in rats. We believe that further preclinical research into the utility of TQ may indicate its usefulness as a potential treatment on neurodegeneration after chronic toluene exposure in rats.     

<Emphasis Type="Italic">Nigella sativa</Emphasis> and Derived Thymoquinone Prevents Hippocampal Neurodegeneration After Chronic Toluene Exposure in Rats

The aim of this study was designed to investigate the possible beneficial effects of Nigella sativa (NS) and derived thymoquinone (TQ) on neurodegeneration in hippocampus after chronic toluene exposure in rats. The rats were randomly allotted into one of four experimental groups: A (control), B (toluene treated), C (toluene treated with NS) and D (toluene treated with TQ); each group contain 10 animals. Toluene treatment was performed by inhalation of 3,000 ppm toluene, in a 8 h/day and 6 day/week order for 12 weeks. Control group received 1 ml serum physiologic and the rats in NS and TQ treated groups (C and D) were given NS (in a dose of 400 mg/kg body weight) and TQ (50 mg/kg body weight) once a day orally by using intra gastric intubation for 12 weeks starting just after toluene exposure respectively. Tissue samples were obtained for histopathological investigation. To date, no histopathological changes of neurodegeneration in hippocampus after chronic toluene exposure in rats by NS and TQ treatment have been reported. In this study, chronic toluene exposure caused severe degenerative changes, shrunken cytoplasma, slightly dilated cisternae of endoplasmic reticulum, markedly swollen mitochondria with degenerated cristae and nuclear membrane breakdown with chromatin disorganization in neurons of the hippocampus. The distorted nerve cells were mainly absent in the TQ and NS-treated rats. We conclude that TQ and especially NS therapy causes morphologic improvement on neurodegeneration in hippocampus after chronic toluene exposure in rats. We believe that further preclinical research into the utility of NS and TQ may indicate its usefulness as a potential treatment on neurodegeneration after chronic toluene exposure in rats.     

Protective effects of thymoquinone on streptozotocin-induced diabetic nephropathy

The aim of this study was designed to investigate the possible beneficial effects of the thymoquinone (TQ) in streptozotocine (STZ)-induced diabetes in rats. The rats were randomly allotted into one of three experimental groups: A (control), B (diabetic untreated), and C (diabetic treated with TQ); each group contain ten animals. B and C groups received STZ. Diabetes was induced in two groups by a single intra-peritoneal (i.p) injection of STZ (50 mg/kg, freshly dissolved in 5 mmol/l citrate buffer, pH 4.5). Two days after STZ treatment, development of diabetes in two experimental groups was confirmed by measuring blood glucose levels in a tail vein blood samples. Rats with blood glucose levels of 250 mg/dl or higher were considered to be diabetic. The rats in TQ treated groups were given TQ (50 mg/kg body weight) once a day orally by using intra gastric intubation for 12 weeks starting 2 days after STZ injection. Treatment of TQ reduced the glomerular size, thickening of capsular, glomerular and tubular basement membranes, increased amounts of mesangial matrix and tubular dilatation and renal function as compared with diabetics untreated. We conclude that TQ therapy causes renal morphologic and functional improvement after STZ-induced diabetes in rats. We believe that further preclinical research into the utility of TQ treatment may indicate its usefulness as a potential treatment in diabetic nephropathy.     

Protective effects of thymoquinone against cholestatic oxidative stress and hepatic damage after biliary obstruction in rats

The aim of this study was to examine the preventive and therapeutic effects of thymoquinone (TQ) against cholestatic oxidative stress and liver damage in common bile duct ligated rats. A total of 24 male Sprague–Dawley rats were divided into three groups: control, bile duct ligation (BDL) and BDL + received TQ; each group contain 8 animals. The rats in TQ treated groups were given TQ (50 mg/kg body weight) once a day orally for 2 weeks starting 3 days prior to BDL operation. To date, no more biochemical and histopathological changes on common bile duct ligated rats by TQ treatment have been reported. The application of BDL clearly increased the tissue hydroxyproline (HP) content, malondialdehyde (MDA) levels and decreased the antioxidant enzyme [superoxide dismutase (SOD), glutathione peroxidase (GPx)] activities. TQ treatment significantly decreased the elevated tissue HP content, and MDA levels and raised the reduced of SOD, and GPx enzymes in the tissues. The changes demonstrating the bile duct proliferation and fibrosis in expanded portal tracts include the extension of proliferated bile ducts into lobules, mononuclear cells, and neutrophil infiltration into the widened portal areas were observed in BDL group. Treatment of BDL with TQ attenuated alterations in liver histology. The immunopositivity of alpha smooth muscle actin and proliferating cell nuclear antigen in BDL were observed to be reduced with the TQ treatment. The present study demonstrates that oral administration of TQ in bile duct ligated rats maintained antioxidant defenses and reduces liver oxidative damage and ductular proliferation. This effect of TQ may be useful in the preservation of liver function in cholestasis.     

霍山石斛胶囊对高脂血症大鼠血脂和脂质过氧化水平的影响

目的：探讨霍山石斛胶囊（Dendrobium huoshenese capsule,DHC）对高脂血症大鼠的血脂影响及脂质过氧化水平作用。方法：采用高脂饲料建立实验性高脂血症大鼠模型,而后进行低、中、高三种剂量的DHC和阳性对照药血脂康实验性治疗,实验8周后,取大鼠血清、肝脏,检测模型大鼠血清总固醇（Total cholesterol,TC）、甘油三酯（Triglyceride,TG）、低密度脂蛋白胆固醇（Low density lipoprotein cholesterol,LDL—C）、高密度脂蛋白胆固醇（High density lipoprotein cholesterol,HDL—C）含量,并计算动脉粥样硬化指数（Atherosclerosis index,AI）;同时测定血清和肝脏超氧化物歧化酶（Superoxide dismutase,SOD）活性及丙二醛（Malondialdehyde,MDA）含量;并计算肝系数,制备大鼠肝脏石蜡切片观察其病理学变化。结果：与高脂血症模型组相比,DHC中、高剂量组和血脂康组能显著降低高脂血大鼠血清TC、TG、LDL-C,升高HDL—C,表现为AI降低;低剂量的DHC能升高HDL—C,但在降低血清TC、TG、LDL．C和AI上无统计学差异（P〉0．05）;除DHC低剂量组对血清SOD活性升高作用不显著外（P〉0．05）,其他各浓度给药组均能显著升高血清和肝脏SOD活性,降低血清和肝脏MDA含量及肝系数（P〈0．05,P〈0．01）;同时,DHC各给药组还可不同程度降低高脂血症大鼠肝细胞的脂肪变性程度。结论：霍山石斛胶囊能调节血脂代谢异常,增强抗氧化能力,具有防治脂肪肝和抗动脉粥样硬化作用。